NDC 66116-504

Pioglitazone

Pioglitazone

Pioglitazone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Medvantx, Inc.. The primary component is Pioglitazone Hydrochloride.

Product ID66116-504_a3ae5cba-f495-4593-b8fc-5ada34790745
NDC66116-504
Product TypeHuman Prescription Drug
Proprietary NamePioglitazone
Generic NamePioglitazone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2012-08-17
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA021073
Labeler NameMedVantx, Inc.
Substance NamePIOGLITAZONE HYDROCHLORIDE
Active Ingredient Strength15 mg/1
Pharm ClassesPeroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 66116-504-30

30 TABLET in 1 BOTTLE (66116-504-30)
Marketing Start Date2012-08-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66116-504-30 [66116050430]

Pioglitazone TABLET
Marketing CategoryNDA authorized generic
Application NumberNDA021073
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-08-17
Inactivation Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
PIOGLITAZONE HYDROCHLORIDE15 mg/1

OpenFDA Data

SPL SET ID:a3ae5cba-f495-4593-b8fc-5ada34790745
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 317573
  • Pharmacological Class

    • Peroxisome Proliferator-activated Receptor Activity [MoA]
    • PPAR alpha [CS]
    • PPAR gamma [CS]
    • Thiazolidinedione [EPC]
    • Thiazolidinediones [CS]
    • Peroxisome Proliferator Receptor alpha Agonist [EPC]
    • Peroxisome Proliferator Receptor gamma Agonist [EPC]

    NDC Crossover Matching brand name "Pioglitazone" or generic name "Pioglitazone"

    NDCBrand NameGeneric Name
    0093-7271PioglitazonePioglitazone
    0093-7272PioglitazonePioglitazone
    0093-7273PioglitazonePioglitazone
    0378-0048Pioglitazonepioglitazone
    0378-0228Pioglitazonepioglitazone
    0378-0318Pioglitazonepioglitazone
    0781-5420Pioglitazonepioglitazone
    0781-5421Pioglitazonepioglitazone
    0781-5422Pioglitazonepioglitazone
    0904-7090PioglitazonePioglitazone
    0904-7096PioglitazonePioglitazone
    16714-645PioglitazonePioglitazone
    16714-646PioglitazonePioglitazone
    16714-647PioglitazonePioglitazone
    16729-020PIOGLITAZONEPIOGLITAZONE
    68071-1621PioglitazonePioglitazone
    68151-3798PioglitazonePioglitazone
    68151-3792PioglitazonePioglitazone
    68382-308pioglitazonepioglitazone
    68382-306pioglitazonepioglitazone
    68382-307pioglitazonepioglitazone
    70518-1815PioglitazonePioglitazone
    70771-1023pioglitazonepioglitazone
    70771-1021pioglitazonepioglitazone
    70771-1022pioglitazonepioglitazone
    71335-0088PioglitazonePioglitazone
    16729-021PIOGLITAZONEPIOGLITAZONE
    16729-022PIOGLITAZONEPIOGLITAZONE
    33342-054PioglitazonePioglitazone
    33342-056PioglitazonePioglitazone
    33342-055PioglitazonePioglitazone
    43547-426PIOGLITAZONEPIOGLITAZONE
    43547-428PIOGLITAZONEPIOGLITAZONE
    43547-427PIOGLITAZONEPIOGLITAZONE
    50090-2637PioglitazonePioglitazone
    50090-2390PioglitazonePioglitazone
    51079-513PioglitazonePioglitazone
    51079-515PioglitazonePioglitazone
    51079-514PioglitazonePioglitazone
    54458-864PioglitazonePioglitazone
    54458-866PioglitazonePioglitazone
    54458-885PioglitazonePioglitazone
    54458-865PioglitazonePioglitazone
    54458-884PioglitazonePioglitazone
    55648-977PioglitazonePioglitazone
    55648-976PioglitazonePioglitazone
    55648-978PioglitazonePioglitazone
    57237-219PioglitazonePioglitazone
    57237-221PioglitazonePioglitazone
    57237-220PioglitazonePioglitazone

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.